Laboratoires Pierre Fabre Relies on Manhattan Associates to Increase Supply Chain Competitiveness

Laboratoires Pierre Fabre Relies on Manhattan Associates to Increase Supply
Chain Competitiveness

PARIS and ATLANTA, April 2, 2013 (GLOBE NEWSWIRE) -- Global supply chain
optimization provider, Manhattan Associates, Inc. (Nasdaq:MANH), today
announced that global pharmaceutical company Laboratoires Pierre Fabre has
selected multiple components from the Manhattan SCOPE® supply chain solutions
portfolio to support its expected business growth. Laboratoires Pierre Fabre
is deploying Manhattan's Warehouse Management, Labor Management and Extended
Enterprise Management (EEM) solutions to improve its supply chain efficiency
and enhance its overall competitiveness in France and around the world.

Tweet this news! Laboratoires Pierre Fabre Relies on @manhassocnews to
increase supply chain competitiveness www.manh.com/news/labpierrefabre

Laboratoires Pierre Fabre, the second largest independent French
pharmaceutical company, has 42 branches, markets its products in more than 130
countries and employs approximately 10,000 people worldwide. Pierre Fabre's
activities cover all aspects of healthcare - from prescription medicines and
family health products to natural healthcare and dermo-cosmetics.

Christophe Ettviller, logistics director at Laboratoires Pierre Fabre SA,
said, "With three separate and diverse operating divisions, multiple product
brands and a global footprint, Laboratoires Pierre Fabre's supply chain must
manage a significant degree of complexity and continually adapt to an
ever-changing market environment. Within that context, it was imperative for
us to standardize our supply chain processes so we could in turn enhance the
service experience for our customers and maximize operational efficiency."

The pharmaceutical industry is one of the most demanding in terms of
logistics, with unique requirements such as expiry dates of products, batch
management and the need for traceability in the form of an audit trail. The
supply chain network needs to facilitate an improved logistics operation
throughout Laboratoires Pierre Fabre's global business, as well as ensure
safety and product compliance.

The implementation project is already underway at Laboratoires Pierre Fabre's
130,000 sq. ft. Ussel warehouse in Corrèze and will soon progress to a second,
860,000 sq. ft Pierre Fabre Dermo-Cosmétique warehouse based in Muret in
Haute-Garonne.

Henri Seroux, managing director at Manhattan Associates France, commented,
"This customer success reinforces our reputation as being able to offer the
most comprehensive supply chain solutions available for addressing the complex
issues associated with the healthcare and pharmaceutical industry."

The Manhattan SCOPE solution components that will be deployed as part of this
project will leverage Manhattan's Supply Chain Process Platform to deliver
cross-application optimization and integration. This means Pierre Fabre group
will be able to run its supply chain operations with less cost and effort
while leveraging best-of-breed supply chain software to improve performance
and efficiency.

Receive up-to-date product, customer and partner news directly from Manhattan
Associates on Twitter and Facebook.

About Laboratoires Pierre Fabre

Pierre Fabre, the second largest independent pharmaceutical group in France,
achieved a turnover of 1.9 billion Euros in 2011, with international sales
accounting for 52 percent. Pierre Fabre has branches in 42 countries and
markets its products in over 130 countries. Their activities cover all aspects
of healthcare, from prescription drugs and family health products to
dermo-cosmetics. The Pierre Fabre Laboratories employ some 10,000 people
worldwide, 1,300 of whom are dedicated to R&D. In 2011, the group allocated 20
percent of its Pharmaceuticals business revenues to R&D, focusing on three
main areas: oncology, dermatology and neuro-psychiatry.

With strong brands such as Avène, A-Derma, Ducray, Galénic, Klorane,
Naturactive, René Furterer and Pierre Fabre Oral Care, Laboratoires Pierre
Fabre is French market n°1 on dermo-cosmetics, hair and dental products sold
in pharmacies and drugstores. Sold in more than 100 countries, Avene is the
leading brand for dermo-cosmetics in Europe, Japan and China. In the field of
medicine, Pierre Fabre focuses on four main branches: oncology, dermatology,
women's health and neuro-psychiatry.

Pierre Fabre already realizes more than 85 percent of its turnover in oncology
internationally.

In 2012, Pierre Fabre became the first pharmaceutical company to be accredited
with AFAQ 2600, a certification delivered by AFNOR assessing corporate social
responsibility.

To learn more about Pierre Fabre: www.pierre-fabre.com

About Manhattan Associates, Inc.

Manhattan Associates continues to deliver on its 23-year heritage of providing
global supply chain excellence to more than 1,200 customers worldwide that
consider supply chain optimization core to their strategic market leadership.
The company's supply chain innovations include: Manhattan SCOPE®, a portfolio
of software solutions and technology that leverages a Supply Chain Process
Platform to help organizations optimize their supply chains from planning
through execution; Manhattan SCALE™, a portfolio of distribution management
and transportation management solutions built on Microsoft .NET technology;
and Manhattan Carrier™, a suite of supply chain solutions specifically
addressing the needs of the motor carrier industry. For more information,
please visit www.manh.com.

CONTACT: Maite Hayet & Christel Sandi
         LEWIS PR
         Tel: +33 1 55 31 98 01 / 98 13
         manhattanfrance@lewispr.com
        
         Yamina Tassin
         Manhattan Associates
         Tel: +33 (1) 76 70 53 82
         ytassin@manh.com
 
Press spacebar to pause and continue. Press esc to stop.